相关实验视频

Updated: Jul 4, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

双特异性抗体的设计和工程:洞察力和实际考虑

Andreas V Madsen¹, Lasse E Pedersen¹, Peter Kristensen²

¹Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.

Frontiers in bioengineering and biotechnology

|February 9, 2024

概括

双特异性抗体 (bsAbs) 为增强疗法提供双重向. 本综述详细介绍了设计考虑和工程原理,以克服在创建高质量BSAbs.的结构复杂性.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
蛋白质工程是指蛋白质工程.

背景情况:

双特异性抗体 (bsAbs) 具有双重结合活性,使其能够同时向抗原,并具有优于单特异性抗体组合的协同效应.
与传统抗体相比,bsAbs的治疗前景受到其结构复杂性增加的实际困难的挑战.

研究的目的:

审查对双特异性抗体的关键设计考虑因素.
总结各种双特异抗体格式的高效构建的最先进的工程原理.

主要方法:

文献综述侧重于双特异抗体的设计和工程.
分析挑战,包括生物物理稳定性和抗体链错配.
探索分子工程战略以提高质量.

主要成果:

设计bsAbs需要仔细考虑结构复杂性,以确保有效性.
分子工程对于克服稳定性降低和杂质形成等挑战至关重要.
可以应用各种工程原理来构建具有所需属性的高质量的bsAbs.

结论:

有效的设计和工程对于实现双特异抗体的治疗潜力至关重要.
解决结构复杂性导致改善生物物理稳定性和减少杂质.
先进的工程方法促进了多样化和高质量的bsAbs的开发.

关键词:

在HC中异构化.在 IgG 融合和 IgG 融合过程中.抗体是一种抗体.两种类型的两种类型的两种类型免疫球蛋白是一种免疫球蛋白.scFvv 在线阅读 sdAb sdAb 在线阅读

更多相关视频

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

Cross-reactivity

Cross-reactivity